A phase III trial (RTOG 0129) of two radiation-cisplatin regimens for head and neck carcinomas (HNC): Impact of radiation and cisplatin intensity on outcome.

被引：30
|
作者：
Ang, K.
Zhang, Q.
Wheeler, R. H.
Rosenthal, D. I.
Nguyen-Tan, F.
Kim, H.
Lu, C.
Axelrod, R. S.
Silverman, C. I.
Weber, R. S.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] RTOG Stat Ctr, Philadelphia, PA USA
[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[4] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[5] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[6] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[7] Univ Louisville, Louisville, KY 40292 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5507
引用
收藏
页数：2
相关论文
共 50 条
  • [31] RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.
    Ilson, David H.
    Moughan, Jennifer
    Suntharalingam, Mohan
    Dicker, Adam
    Kachnic, Lisa A.
    Konski, Andre A.
    Chakravarthy, Bapsi
    Anker, Chris
    Thakrar, Harish V.
    Horiba, Naomi
    Kavadi, Vivek
    Deutsch, Melvin
    Raben, Adam
    Roof, Kevin S.
    Suh, John H.
    Pollock, Jondavid
    Safran, Howard
    Crane, Christopher H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] IMPROVED RESPONSE AND SURVIVAL TO COMBINED CISPLATIN AND RADIATION IN NON-KERATINIZING SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK - AN RTOG STUDY OF 114 ADVANCED STAGE TUMORS
    CRISSMAN, JD
    PAJAK, TF
    ZARBO, RJ
    MARCIAL, VA
    ALSARRAF, M
    CANCER, 1987, 59 (08) : 1391 - 1397
  • [33] Phase III trial of antioxidant vitamins to prevent acute side effects of radiation therapy in head and neck cancer (HNC) patients.
    Bairati, I
    Meyer, F
    Fortin, A
    Têtu, B
    Harel, F
    Abdous, B
    Gélinas, M
    Nabid, A
    Brochet, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 196S - 196S
  • [34] Phase I Trial of Bevacizumab followed by Concurrent Radiation, Bevacizumab and Cisplatin for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
    Harari, P. M.
    Khuntia, D.
    Traynor, A. M.
    Hoang, T.
    Hartig, G. K.
    McCulloch, T. M.
    Jeraj, R.
    Nyflot, M.
    Wiederholt, P. A.
    Gentry, L. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S104 - S104
  • [35] Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer
    Rasmussen, Jacob H.
    Hakansson, Katrin
    Vogelius, Ivan R.
    Aznar, Marianne C.
    Fischer, Barbara M.
    Friborg, Jeppe
    Loft, Annika
    Kristensen, Claus A.
    Bentzen, Soren M.
    Specht, Lena
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 (01) : 76 - 80
  • [36] Concurrent Intensity Modulated Radiation Therapy (IMRT) With Cisplatin (CDDP) versus 5-Fluorouracil/Carboplatin (5FU/P) For Head and Neck Cancer (HNC)
    Shapiro, L. Q.
    Setton, J.
    Zhang, Z.
    Shi, W.
    Rao, S. D.
    Wolden, S. A.
    Sherman, E. J.
    Kraus, D. H.
    Pfister, D. G.
    Lee, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S493 - S493
  • [37] The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery
    Suntharalingam, Mohan
    Winter, Kathryn
    Ilson, David H.
    Dicker, Adam
    Kachnic, Lisa A.
    Konski, Andre A.
    Chakravarthy, Bapsi
    Gaffney, David K.
    Thakrar, Harish V.
    Horiba, Margit Naomi
    Deutsch, Melvin
    Kavadi, Vivek
    Raben, Adam
    Roof, Kevin S.
    Videtic, Gregory M. M.
    Pollock, Jondavid
    Safran, Howard
    Crane, Christopher H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [38] Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT)
    Hoebers, Frank J. P.
    Pluim, Dick
    Verheij, Marcel
    Balm, Alfons J. M.
    Bartelink, Harry
    Schellens, Jan H. M.
    Begg, Adrian C.
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (04) : 750 - 756
  • [39] A Phase 1-2 Trial of Concurrent Radiation Therapy, Cisplatin and BMX-001 in Locally Advanced Head and Neck Cancer
    Brizel, D. M.
    Mowery, Y. M.
    Zhen, W.
    Chan, J.
    Macleod, D.
    Yom, S. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S145 - S145
  • [40] Long term results of a phase II trial of hyperfractionated radiation and intraarterial cisplatin (HYPERRADPLAT) on stage III-IV head and neck cancer with bulky primary tumors
    Warren, G. W.
    Arnold, S.
    Valentino, J.
    Brill, Y.
    Regine, W.
    Spring, P.
    Given, C.
    Mohiuddin, M.
    Meigooni, A.
    Kudrimoti, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S429 - S429
12345